| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Sunnybrook Research Institute, and Department of Immunology, University of Toronto, Toronto, Ontario, Canada; and
Division of Biology, California Institute of Technology, Pasadena, CA 91106
The basic helix-loop-helix (bHLH) transcription factors HEB and E2A are critical mediators of gene regulation during lymphocyte development. We have cloned a new transcription factor, called HEBAlt, from a pro-T cell cDNA library. HEBAlt is generated by alternative transcriptional initiation and splicing from the HEB gene locus, which also encodes the previously characterized E box protein HEBCan. HEBAlt contains a unique N-terminal coding exon (the Alt domain) that replaces the first transactivation domain of HEBCan. Downstream of the Alt domain, HEBAlt is identical to HEBCan, including the DNA binding domain. HEBAlt is induced in early thymocyte precursors and down-regulated permanently at the double negative to double positive (DP) transition, whereas HEBCan mRNA expression peaks at the DP stage of thymocyte development. HEBAlt mRNA is up-regulated synergistically by a combination of HEBCan activity and Delta-Notch signaling. Retroviral transduction of HEBAlt or HEBCan into hemopoietic stem cells followed by OP9-DL1 coculture revealed that HEBAlt-transduced precursors generated more early T lineage precursors and more DP pre-T cells than control transduced cells. By contrast, HEBCan-transduced cells that maintained high level expression of the HEBCan transgene were inhibited in expansion and progression through T cell development. HEB–/– fetal liver precursors transduced with HEBAlt were rescued from delayed T cell specification, but HEBCan-transduced HEB–/– precursors were not. Therefore, HEBAlt and HEBCan are functionally distinct transcription factors, and HEBAlt is specifically required for the efficient generation of early T cell precursors.
This article has been cited by other articles:
|
|
 |
|
  K. Beck, M. M. Peak, T. Ota, D. Nemazee, and C. Murre Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci J. Exp. Med., September 28, 2009; 206(10): 2271 - 2284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guo, Q. Hu, C. Yan, and J. Zhang Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery Mol. Cell. Biol., May 15, 2009; 29(10): 2644 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Georgescu, W. J. R. Longabaugh, D. D. Scripture-Adams, E.-S. David-Fung, M. A. Yui, M. A. Zarnegar, H. Bolouri, and E. V. Rothenberg Gene Networks in Development and Evolution Special Feature Sackler Colloquium: A gene regulatory network armature for T lymphocyte specification PNAS, December 23, 2008; 105(51): 20100 - 20105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bhalla, C. Spaulding, R. L. Brumbaugh, D. E. Zagort, M. E. Massari, C. Murre, and B. L. Kee Differential Roles for the E2A Activation Domains in B Lymphocytes and Macrophages J. Immunol., February 1, 2008; 180(3): 1694 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Tydell, E.-S. David-Fung, J. E. Moore, L. Rowen, T. Taghon, and E. V. Rothenberg Molecular Dissection of Prethymic Progenitor Entry into the T Lymphocyte Developmental Pathway J. Immunol., July 1, 2007; 179(1): 421 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu and B. L. Kee Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas Blood, May 15, 2007; 109(10): 4406 - 4414. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
